New cancer drugs are very expensive: here’s how we work out value for our money.

Research output: Other contribution

Abstract

The Senate Standing Committee on Community Affairs is expected to table its report on the “Availability of new, innovative and specialist cancer drugs in Australia” today. Initiated by South Australian senator Nick Xenophon, the inquiry, which was initially slated to report in late March, is focusing on timely access and affordability of cancer drugs, and how this impacts the quality of cancer care.
Original languageEnglish
PublisherThe Conversation
Place of PublicationAustralia
Publication statusPublished - 9 Sep 2015
Externally publishedYes

Keywords

  • PBS
  • health economics
  • PBAC
  • cancer drugs

Fingerprint Dive into the research topics of 'New cancer drugs are very expensive: here’s how we work out value for our money.'. Together they form a unique fingerprint.

  • Cite this